Drug Type Small molecule drug |
Synonyms LC 231306, LC23-1306 |
Target |
Action antagonists |
Mechanism P2Y12 receptor antagonists(Purinergic receptor P2Y12 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Coronary Syndrome | Phase 1 | South Korea | 01 Mar 2012 |
Phase 1 | 113 | (LC23-1306) | hyovaobvrj = huumeesvzq qqthwryjbq (tpapwzyjht, uwvdturoap - szqgpivsyw) View more | - | 13 Aug 2018 | ||
placebo (Placebo) | hyovaobvrj = sxwlbjamdq qqthwryjbq (tpapwzyjht, wkqwpqcydv - ajykoiidkc) View more |





